Cargando…
Double-modified oncolytic adenovirus armed with a recombinant interferon-like gene enhanced abscopal effects against malignant glioma
BACKGROUND: The development of new therapies for malignant gliomas has been stagnant for decades. Through the promising outcomes in clinical trials of oncolytic virotherapy, there is now a glimmer of hope in addressing this situation. To further enhance the antitumor immune response of oncolytic vir...
Autores principales: | Jiang, Shan, Chai, Hui-Hui, Fang, Xian-Long, Xu, Hou-Shi, Li, Tian-Wen, Tang, Qi-Sheng, Gu, Jin-Fa, Zhang, Kang-Jian, Liu, Xin-Yuan, Shi, Zhi-Feng, Cao, Xue-Ping, Wu, Zan-Yi, Zhou, Liang-Fu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572777/ https://www.ncbi.nlm.nih.gov/pubmed/37841695 http://dx.doi.org/10.1093/noajnl/vdad117 |
Ejemplares similares
-
GITRL-armed Delta-24-RGD oncolytic adenovirus prolongs survival and induces anti-glioma immune memory
por: Rivera-Molina, Yisel, et al.
Publicado: (2019) -
Low-dose oncolytic adenovirus therapy overcomes tumor-induced immune suppression and sensitizes intracranial gliomas to anti-PD-1 therapy
por: Belcaid, Zineb, et al.
Publicado: (2020) -
Abscopal Effect in Non-injected Tumors Achieved with Cytokine-Armed Oncolytic Adenovirus
por: Havunen, Riikka, et al.
Publicado: (2018) -
Fatty acid oxidation is required for the respiration and proliferation of
malignant glioma cells
por: Lin, Hua, et al.
Publicado: (2017) -
FoundationOne CDx testing accurately determines whole arm 1p19q codeletion status in gliomas
por: Sharaf, Radwa, et al.
Publicado: (2021)